PlainVisa
2026 data Public-data reference Official source

BioMarin Pharmaceutical Inc.

A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.

DOL LCA filings
104
DOL-certified
99%
Median offered wage
$132,769

Novato, CA NAICS: 325414

How many H-1B LCA filings list BioMarin Pharmaceutical Inc.?

U.S. Department of Labor's OFLC discloses 104 Labor Condition Application filings naming BioMarin Pharmaceutical Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs

How many H-1B petitions has USCIS approved for BioMarin Pharmaceutical Inc.?

Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 229 H-1B petitions naming BioMarin Pharmaceutical Inc. through FY2024, and approved nearly every one of them: 98.3% approved (225 approvals, 4 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.

The verdict

BioMarin Pharmaceutical Inc. is listed in 104 DOL LCA filings, more filings than 98% of employer filers in this extract. DOL certified 99% of those LCAs; the median listed offered wage is $132,769. This is not a USCIS approval, hiring, or sponsorship ranking.

104
DOL LCA filings, FY2023–FY2026
99%
DOL-certified
$132,769
median offered wage
Top 2%
of employer filers by volume

According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Novato, CA.

Saved on this device only, no account, no email. Open saved list Follow this profile's data updates Updates when the published DOL data vintage changes; this is a feed, not an alert service.

BioMarin Pharmaceutical Inc. vs all U.S. employer filers by LCA volume

Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)

104 2421st of 122824 higher than 120,403 of 122,824 employer filers

Employer filers, banded by disclosed H-1B LCA filing count

Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source U.S. Department of Labor OFLC · FY2023–FY2026

LCA filing shape · BioMarin Pharmaceutical Inc.

Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.

Offered-wage span on file: $60,757$252,331 .

Title concentration

  • Scientist 1, Tech Ops 3 · 2.9% · $111,374
  • Scientist 1, Gene Therapy Research 3 · 2.9% · $130,763
  • VP, Head of Commercial Digital Strategy and Transformation 2 · 1.9% · $235,934
  • Technical Manager, External Quality 2 · 1.9% · $120,078
  • Sr. Research Associate 1, Tech Ops 2 · 1.9% · $102,441

Worksite counties

  • MARIN, CA 77 · 84.6%
  • DENTON, TX 2 · 2.2%
  • SACRAMENTO, CA 2 · 2.2%
  • BURLINGTON, NJ 2 · 2.2%
  • LOS ANGELES, CA 2 · 2.2%

DOL LCA release change

What changed between the two LCA fiscal years

FY2024 -> FY2025
  • BioMarin Pharmaceutical Inc.'s disclosed H-1B LCA filing count rose from 25 in FY2024 to 36 in FY2025 (+44%).
  • BioMarin Pharmaceutical Inc.'s average disclosed H-1B offered wage rose from $123,248 in FY2024 to $142,854 in FY2025 (+15.9%).

Arithmetic differences between stored DOL OFLC Labor Condition Application disclosure fiscal years for this employer identity - not a headcount, hire forecast, or cause claim. Role mix can shift between years even when the filing total is flat. Totals group name variants that share the same identity key.

National filing changes Two-year CSV

National-scale filing footprint

BioMarin Pharmaceutical Inc. has filed 104 LCAs (more volume than 98% of U.S. employer filers in this extract). DOL certification: 99%. Worksites span 6 states , led by CA.

Marin, CA worksite concentration

Only 104 LCAs on file for BioMarin Pharmaceutical Inc., and 76.9% land in MARIN, CA. Treat rates as descriptive of a small sample. DOL cert on file: 99%.

Certification Rate

99%

Very high DOL cert

Avg. Salary

$132,769

Above portal avg

Total Workers

104

Moderate worker count

Compare with another employer filer

BioMarin Pharmaceutical Inc. vs a peer vs the national average, from DOL LCA data.

Avg. offered wage$132,769 · 26% lower than Google LLC
This filer
Peer
$180,539
National avg.
$113,357
Certification rate99.0% · 1% higher than Google LLC
This filer
Peer
98.5%
National avg.
97.7%
Total LCA filings104 · 100% lower than Google LLC
This filer
Peer
33,631
National avg.
17
FY2025 filings are 97% of FY2023

37 completed-year filings in FY2023, 36 in FY2025. The scale spans up to twice the earlier year's count: the midpoint is unchanged and the endpoint is at least doubled.

Wondering how long it takes USCIS to process an H-1B petition for this employer? See current I-129 processing times →

Salary Analysis

Compensation range for H-1B positions at BioMarin Pharmaceutical Inc.

Minimum
$60,757
Maximum
$252,331
Average Salary
$132,769

LCA Filing History

H-1B LCA filing trends from FY2023 to FY2026

FY2023 37 LCA filings · 100% DOL-certified · $129,400 avg
FY2024 25 LCA filings · 96% DOL-certified · $10,524,142 avg
FY2025 36 LCA filings · 100% DOL-certified · $142,854 avg

FY2026 is partial on this extract. Chart shows completed fiscal years only (through FY2025).

Top Occupations

Most frequently listed job titles at BioMarin Pharmaceutical Inc.

Job Title LCA filings Avg. Salary
Scientist 1, Tech Ops 3 $111,374
Scientist 1, Gene Therapy Research 3 $130,763
VP, Head of Commercial Digital Strategy and Transformation 2 $235,934
Technical Manager, External Quality 2 $120,078
Sr. Research Associate 1, Tech Ops 2 $102,441
Sr. Research Associate 1, Oligo. Protein Bioconjugate Prod. 2 $112,549
Sr. Manager, US Health Economics and Value Demonstration 2 $101,046
Sr. Manager, In Vivo Lead, Hematology Research 2 $130,135,335
Sr. Manager, Commercial CFIT Solutions Delivery 2 $148,491
Sr. Business Systems Analysis Manager 2 $183,368
Senior Manager, Regulatory Affairs 2 $143,562
Senior IM Business Systems Analyst Manager 2 $164,798
Senior Analyst, QC Analytical Training and Validation 2 $76,461
Scientist I, Pharmacology/Toxicology 2 $96,800
Scientist 2, Neuroscience Research 2 $116,000

Geographic Distribution

Where BioMarin Pharmaceutical Inc. places H-1B workers across the United States

CA 93 LCA filings
TX 2 LCA filings
NJ 2 LCA filings
GA 1 LCA filings
WA 1 LCA filings
IL 1 LCA filings

Nationwide peers near BioMarin Pharmaceutical Inc.'s 104-LCA band

Cross-state DOL neighbors for BioMarin Pharmaceutical Inc. - LCA filing-count and offered-wage axes, outside CA.

Similar LCA filing volume

Nearest cross-state employer filers by LCA filing count (104 here; floor ≥10 LCA filings).

Similar avg offered wage

Cross-state employer filers with a comparable average listed offered wage ($132,769 here).

Disclaimer: Informational only, not professional advice.

Read with BioMarin Pharmaceutical Inc.

ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.

What to do with this profile

Use the DOL LCA record for BioMarin Pharmaceutical Inc. to compare filing volume and offered wages, not USCIS outcomes.

DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.

Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.